Showing results (2341-2350 of 2,449) with videos related to

Sort By:
Pageof 245
FEBS Open Bio|May 11, 2023
Diacylglycerol kinase ζ interacts with sphingomyelin synthase 1 and sphingomyelin synthase-related protein via different regionsMasataka Furuta, Chiaki Murakami, Yuki Numagami, et al.
FEBS Open Bio|May 9, 2023
CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL modelZhaohui Wang, Jihong Ma, Huiping Zhang, et al.
FEBS Open Bio|May 23, 2023
Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820
FEBS Open Bio|March 27, 2021
Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cellsNoriyuki Egawa, Tomokazu Tanaka, Shohei Matsufuji, et al.
FEBS Open Bio|August 19, 2020
Microarray-based transcriptional profiling of a mouse model of autoimmune hepatitisYang Liu, Hao Chen, Jian-Heng Hao, et al.
FEBS Open Bio|August 20, 2020
IbpB-bound substrate release in living cells as revealed by unnatural amino acid-mediated photo-crosslinkingXiaodong Shi, Anastasia N Ezemaduka
FEBS Open Bio|April 4, 2023
Withdrawal statement: [Liu, X., Qiao, L., Zhang, H., Zhang, C., Ding, R., Kang, J., Liu, Y., Lin, J. and Yan, X. (2023), Argonaute 2 regulates LPS-induced inflammation in microglial BV2 cells by targeting Cadm1. FEBS Open Bio. Accepted Author Manuscript]
FEBS Open Bio|August 15, 2020
Expression of genes involved in drug metabolism differs between perfusable 3D liver tissue and conventional 2D-cultured hepatocellular carcinoma cellsNobuhito Mori, Yasuyuki S Kida
FEBS Open Bio|August 19, 2020
The transcriptional response of Arcobacter butzleri to cold shockXiaochen Zhang, Yulan Su, Thomas Alter, et al.
FEBS Open Bio|August 19, 2020
Upregulation of CIP2A in estrogen depletion-resistant breast cancer cells treated with low-dose everolimusEiji Nishio, Takanori Hayashi, Mao Akaza, et al.
Pageof 245